Acquired amegakaryocytic thrombocytopenia after durvalumab administration

Immune checkpoint inhibitors (ICIs), despite their ability to potentiate antitumor T-cell responses, may cause various immune-related adverse events. Most cases of thrombocytopenia induced by ICIs have revealed a pathophysiologic mechanism of immune thrombocytopenia with increased platelet destructi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Exp Hematop
Main Authors: Suyama, Takahiro, Hagihara, Masao, Kubota, Naoto, Osamura, Yoshiyuki, Shinka, Yoko, Miyao, Naoki
Format: Artigo
Sprog:Inglês
Udgivet: JSLRT 2021
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8053569/
https://ncbi.nlm.nih.gov/pubmed/33431742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.20047
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker